Are women underrepresented in cerebrovascular disease clinical trials? A systematic review using the FDA database
View ORCID ProfileXiaobo Zhong, View ORCID ProfileQing Hao
doi: https://doi.org/10.1101/2020.11.09.20227207
Xiaobo Zhong
1Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY
DrPHQing Hao
2Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY
MD, PhD
Posted November 12, 2020.
Are women underrepresented in cerebrovascular disease clinical trials? A systematic review using the FDA database
Xiaobo Zhong, Qing Hao
medRxiv 2020.11.09.20227207; doi: https://doi.org/10.1101/2020.11.09.20227207
Subject Area
Subject Areas
- Addiction Medicine (382)
- Allergy and Immunology (699)
- Anesthesia (190)
- Cardiovascular Medicine (2837)
- Dermatology (243)
- Emergency Medicine (427)
- Epidemiology (12545)
- Forensic Medicine (10)
- Gastroenterology (801)
- Genetic and Genomic Medicine (4419)
- Geriatric Medicine (401)
- Health Economics (712)
- Health Informatics (2845)
- Health Policy (1046)
- Hematology (373)
- HIV/AIDS (893)
- Medical Education (413)
- Medical Ethics (114)
- Nephrology (461)
- Neurology (4173)
- Nursing (220)
- Nutrition (615)
- Oncology (2199)
- Ophthalmology (623)
- Orthopedics (254)
- Otolaryngology (317)
- Pain Medicine (266)
- Palliative Medicine (81)
- Pathology (485)
- Pediatrics (1171)
- Primary Care Research (482)
- Public and Global Health (6764)
- Radiology and Imaging (1487)
- Respiratory Medicine (897)
- Rheumatology (430)
- Sports Medicine (368)
- Surgery (472)
- Toxicology (57)
- Transplantation (200)
- Urology (173)